Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Miguel Angel Hernandez Mezquita (Aldeatejada, Spain), Miguel Angel Hernandez Mezquita, Alexis Morales Boscam, Vanesa Hidalgo Sierra, Mercedes Sobrino Ballesteros, Miguel Barrueco Ferrero. Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13). Eur Respir J 2016; 48: Suppl. 60, 2632

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness data on prevention of COPD exacerbations with 13-valent pneumococal conjugate vaccine (PCV13) Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Pneumococcal vaccination: Effects on exacerbation of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough. Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Pneumococcal vaccine in steroid-dependent COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 The importance of pneumococcal and influenza vaccines in patients with allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients Source: International Congress 2015 – Different data in COPD Year: 2015 No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Australian perceptions of pertussis and vaccine preventable disease in the setting of asthma and COPD Source: International Congress 2019 – Airway infection in COPD Year: 2019 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain) Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021